NCT07079904 Laser-assisted Ultrasound-guided Peripheral Vein Cannulation in Cardiac Surgery
| NCT ID | NCT07079904 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanjing First Hospital, Nanjing Medical University |
| Condition | Ultrasonography, Interventional |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-07-24 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-07-24 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this clinical trial is to investigate the advantages of single-operator laser-assisted ultrasound-guidance comparing with traditional ultrasound guidance in peripheral venous catheterization.The primary question addressed is whether single-operator laser-assisted ultrasound-guidance could improve the first-attempt success rate of peripheral venous catheterization compared with traditional ultrasound guidance.
Eligibility Criteria
Inclusion Criteria: 1. aged 18-80 years 2. BMI 18-30 kg/m² 3. ASA classification 1-4 Exclusion Criteria: 1. infection or hematoma at the puncture site 2. patients mentally unstable or unable to cooperate 3. patient refused to participate
Contact & Investigator
Shuai Wang
STUDY CHAIR
Nanjing First Hospital, Nanjing Medical University
Frequently Asked Questions
Who can join the NCT07079904 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Ultrasonography, Interventional. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07079904 currently recruiting?
Yes, NCT07079904 is actively recruiting participants. Contact the research team at wangshuaisj@126.com for enrollment information.
Where is the NCT07079904 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT07079904 clinical trial?
NCT07079904 is sponsored by Nanjing First Hospital, Nanjing Medical University. The principal investigator is Shuai Wang at Nanjing First Hospital, Nanjing Medical University. The trial plans to enroll 100 participants.